Headquartered in New York, NY, Vivax Bio is a biotech company focusing on 3D bioprinting and the hardware, materials, technologies, and products related to the industry. Their product pipeline comprises the FABION bioprinter, a new line of bioprinters based on different technologies, including in situ portable bioprinters, and various tissue and organ constructs. Most of Vivax BIo's research and development is based in Moscow, Russia, where their wholly owned subsidiary, 3D Bioprinting Solutions, is located.
As of November 2018, the company focused on cultured meat. The company thinks that 3D bioprinting, by bringing automation, standardization, and speed, has a huge cost-reduction potential for the cultured meat industry. Vivax Bio will launch its magnetic bioprinter, Organ.Aut, on board the ISS, and hope to use this participation in the international space program as a stepping stone towards bringing cultured/printed meat to consumers.
President, Vivax Bio and CEO, 3D Bioprinting Solutions
Documentaries, videos and podcasts
- 3D bioprinting
- BioprintingA method for creating replacement skin, bone, muscle and organs.
- 3D Bioprinting Solutions3D Bioprinting Solutions is a Laboratory for Biotechnological Research founded by INVITRO, the largest private medical company in Russia. The laboratory develops and produces bioprinters and materials for 3D bioprinting, and also develops technologies in the field of biofabrication. 3D Bioprinting Solutions Laboratory opened on September 6, 2013.